Their complaint states the final rule “purports to further that objective [of bringing down prices] but will instead frustrate it – by misleading patients about their out-of-pocket costs for prescription drugs in a manner that even the Department of Health and Human Services admits may ‘confuse’ and ‘intimidate’ patients”.
이 소식을 빠르게 읽을 수 있도록 요약했습니다. 뉴스에 관심이 있으시면 여기에서 전문을 읽으실 수 있습니다. 더 많은 것을 읽으십시오:
Uh oh, seems like the President has touched a nerve in BigPharma. Good.
About time someone was brave enough to take on the drug companies 👏
Persian famine of 1917–1919 The .'Persian holocaust.' !
Time for RegimechangeinUS AwaywithTrump realDonaldTrump